"...albeit on a greatly extended timeline to what we, and they, may have initially hoped..."
??? You make that sound like a negative SI. Their recruitment rate was almost exactly as planned. The completion date estimate was based on an estimated PFS improvement prior to having data beyond PhII ....which was a different treatment regime all together.
It certainly isn't a negative reflection on the company that the trial took longer than expected. I was hoping for a much longer timeline than expected. And that's what it looks like has happened.
Observations that make me reasonably comfortable, page-5
Add to My Watchlist
What is My Watchlist?